Pharmaceuticals Market Research Reports & Industry Analysis
Filter your search
Research Assistance
Pharmaceuticals Industry Research & Market Reports
-
Global Cancer Diagnostics Market Overview 2021: Test Volume and Sales Forecasts by Country, Laboratory Universe
...etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country. Contains 11 pages and 3 tables Please note: The ... Read More
-
Emerging Cancer Diagnostic Tests and Strategic Assessments of Leading Suppliers
...and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others. The report includes an overview of the clinical significance and market needs for both current and ... Read More
-
Europe Hepatitis Markers Testing Market 2021: Supplier Shares and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Procedures - Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices
...analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the five-year test volume and sales forecasts ... Read More
-
Tumor Markers Testing Instrumentation Review: Cancer Diagnostic Analyzers and Strategic Profiles of Leading Suppliers
...testing. The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains ... Read More
-
Cancer Diagnostic Instrumentation Review: Tumor Marker Testing Analyzers and Strategic Profiles of Leading Suppliers
...testing. The report also presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. ... Read More
-
Global Hepatitis Markers Testing Market 2021: Supplier Shares and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Procedures - Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices
...analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the 5-year test ... Read More
-
Chemical and Pharmaceutical Plants (Construction) in Bulgaria: Market Analytics by Category & Cost Type to 2021
...contains historic and forecast market data for the chemical and pharmaceutical plants category in Bulgaria, it also provides detailed breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition) and ... Read More
-
Thailand Pharmaceuticals and Healthcare Report Q3 2017
...the mounting downward pressure on pharmaceutical prices through calls for declaration ofproduction costs, and the worsening demographic profile, the attractiveness of the country'spharmaceutical and healthcare markets will diminish, unless the issues are addressed. Thailand's business ... Read More
-
Asia Pharmaceuticals and Healthcare Report Q3 2017
...cost drugs. Innovativemedicines will continue to generate the majority of revenues from North America and Europe; however, thedeveloping pharmaceutical markets of emerging Asian markets, in particular China and India, will boostgeneric drugmaker opportunities. A country-specific ... Read More
-
China Pharmaceuticals and Healthcare Report Q3 2017
...distributionregime changes will pose downsides to our forecasts. Nevertheless, the size of the market and the overalltrend towards regulatory improvement will continue to provide major draws. Latest Updates In May 2017, Levena Biopharma (Sorrento Therapeutics) ... Read More
-
Portugal Pharmaceuticals and Healthcare Report Q3 2017
...pharmaceutical firms operating in thecountry, hindering the market's attractiveness to drugmakers throughout 2017 and in the coming years. Inaddition, although the ageing population will continue to drive demand for healthcare upwards, sloweconomic growth will translate ... Read More
-
Sub-Saharan Africa Pharmaceuticals and Healthcare Report Q3 2017
...Healthcaresystems in the region are significantly underdeveloped and governments' focus on the containment ofinfectious diseases present less receptive markets for innovative drugmakers. The long-term outlook isbrighter, with the expansion of national health insurance schemes and ... Read More
-
Latin America Pharmaceuticals and Healthcare Report Q3 2017
...remains a positive for long-term prospects, with the expansion of public medical services toprovide significant commercial opportunities. Risk/Reward Index The Americas region will remain characterised by highly divergent levels of attractiveness for innovativepharmaceutical firms. While ... Read More
-
Global Alzheimer's Drugs Market 2017-2021
...years and above and affects more women than men. As per the Centers for Disease Control and Prevention (CDC), 5.4 million Americans are affected by this disease, and the incidence rate of disease increases with ... Read More
-
Zambia Pharmaceuticals and Healthcare Report Q3 2017
...impact on antiretroviral(ARV) drugmakers in South Africa - currently one of Zambia's key medicine import partners. Although local manufacturing of ARVs will be positive for the domestic industry, we do not expect importreliance to drop ... Read More
-
Norway Pharmaceuticals and Healthcare Report Q3 2017
...create commercialopportunities for innovative drugmakers over the forecast period. That said, Norway's small drug market byregional standards, as well as high labour costs, will keep a lid on the country's potential appeal topharmaceutical investors. Meanwhile, ... Read More
-
Qatar Pharmaceuticals and Healthcare Report Q3 2017
...drug market, high per capita drug spending and rising lifestyle diseases will create renewedcommercial opportunities for multinational drugmakers. Given a high market share by patented drugs, aswell as limited domestic drug manufacturing capacity, pharmaceutical imports ... Read More
-
Tunisia Pharmaceuticals and Healthcare Report Q3 2017
...theback of structural reforms, underlying regulatory and operational issues will remain a deterrent formultinational pharmaceutical investment in the local production of medicines. In April 2017, Tunisia adopted a new investment code aimed at simplifying procedures ... Read More
-
Japan Pharmaceuticals and Healthcare Report Q3 2017
...to creatingrevenue-earning opportunities for drugmakers. However, an increasingly tough pricing environment and apush towards the consumption of generic medicine, will require drugmakers to review their sellingstrategies in the world's second largest pharmaceutical market. Latest Updates ... Read More
-
Pakistan Pharmaceuticals and Healthcare Report Q3 2017
...unattractive policy environment will continue to prevent significant levels ofinvestment by foreign pharmaceutical firms. We do not expect this to improve over the coming quarters asthe Drug Regulatory Authority of Pakistan is restrained by both ... Read More
-
Panama Pharmaceuticals and Healthcare Report Q3 2017
...environment, Panama willcontinue to represent a low-risk, low-reward market for companies looking to launch a high-value drug inLatin America. While drug spending per capita will remain high by regional standards, the small absolutesize of Panama's ... Read More
-
Europe Pharmaceuticals and Healthcare Report Q3 2017
...chronic disease medicines through ageing populations. In emerging Europe, market growth willbe robust, driven by the rapid expansion of healthcare access. Europe is a region with a high degree of variability of market attractiveness for ... Read More
-
Global Retinal Drugs Market 2017-2021
...of critical disorders may even lead to vision loss. Retinal disorders, glaucoma, dry-eye, infection/inflammation in the eyes, and allergic/otic problems are the major ophthalmic disorders. The retinal drugs market holds the largest share of the ... Read More
-
Costa Rica Pharmaceuticals and Healthcare Report Q3 2017
...rise as a medical tourism destination. Generally speaking, the country's friendly business environment and improving regulatory pathways willcontinue to align with its wider program to attract foreign direct investment as a key part of the ... Read More
-
Turkey Pharmaceuticals and Healthcare Report Q3 2017
...the country's regulatory environment and government's pharmaceutical policies willdeter innovative drugmakers, while the weakness of the lira will erode revenues. Nevertheless, the countryremains a key market in the region. Highlighting Turkey's potential as a pharmaceutical ... Read More
